![]() |
![]() |
||||
|
||||||||||||
Our ApproachWe Measure What Matters Consistently evaluating critical outcome measures is the key objective in ensuring effective and meaninful clinical trials. The CAP program accomplishes this objective with three distinct but complementary services. First, CAP's experts participate in protocol design aimed at optimizing both primary and secondary endpoints and the mechanisms to collect them. Second, CAP provides protocol and indication-specific training of assessors and study team members using a variety of methods including in-person, on-site training performed by CAP-certified site educators, customized educational materials such as handbooks an tip cards, and other tools such as websites and digital video. Third, CAP utilizes its unique data quality management program that provides continous review and analysis of endpoint data to ensure assessor accuracy and consistency. Errors and other data anomalies identified by CAP's analysis resullt in prompt action to resolve issues before they become systemic. Using blinded data modeling and analysis, outcomes are mapped and tracked to provide study data trends. CAP's program has markedly reduced investigator and assessor errors, greatly improved data accuracy and shortened the time to data lock. In addition, the program has been well received by the FDA and other regulatory agencies. Understand the Medical Condition and Customize the Program to the Endpoints Unparalleled Training and Education Real Time Study Management and Performance Tracking CAP Program Goals and Objectives While specific goals and objectives may vary from client to client and from project to project, the following four program goals and objectives constantly guide the CAP team. 1. Facilitate healthy interaction among sites, vendors, and the sponsor by providing an organized, responsive and accountable clinical management team; 2. Standardize and ensure consistency of study endpoint assessments for all investigative sites; 3. Maximize assessor accuracy and compliance by closely tracking critical endpoint data while patients are still on study, and; 4. Shorten the time to database lock following study completion by reducing the number of clinical data clarification requests. |
we measure what matters |
|||||||||||
![]() |
||||||||||||
Clinical Assistance Programs ©2002-2008 All Rights Reserved | Privacy Policy |
||||||||||||